BHEL vs Gammon India Ltd
A side-by-side comparison of BHEL (BHEL) and Gammon India Ltd (GAMMONIND) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.
On the numbers, BHEL leads BHEL vs GAMMONIND on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).
- Valuation22
- Profitability31
- Growth10
- Size & financial health31
Valuation
EvenHow expensive each stock is relative to its earnings and book value. Lower usually means cheaper.
Profitability
BHEL takes 3/4How efficiently each company turns capital and sales into profit. Higher is better.
Growth
BHEL takes 1/2Three-year compounded growth. Faster-growing businesses can justify a higher valuation.
Size & financial health
BHEL takes 3/4Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.
- + ["Company is expected to give good quarter", "Company has delivered good profit growth of 20.9% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 31.3%"]
- − ["Stock is trading at 5.74 times its book value", "Company has a low return on equity of 3.18% over last 3 years.", "Promoter holding has decreased over last 3 years: -5.00%"]
- + ["Debtor days have improved from 179 to 117 days."]
- − ["Company has low interest coverage ratio.", "The company has delivered a poor sales growth of 11.6% over past five years.", "Promoter holding is low: 11.6%", "Contingent liabilities of Rs.871 Cr.", "Promoters have pledged 84.8% of their holding.", "Company's cost of borrowing seems high"]
This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.